{"transactions":[{"id":712032,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2026-07-09T20:11:27.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":6800,"price":5.29,"value":35972.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on July 7, 2027."}],"balance_after":6800,"derivative":{"exercise_price":5.29,"expiration_date":"2036-07-06","underlying":"Common Stock","underlying_shares":6800},"source":{"system":"sec-edgar","filing":"0001108205-26-000092","document":"wk-form4_1783627883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820526000092/wk-form4_1783627883.xml","form_type":"4"}},{"id":730684,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:14:58.000Z","date":"2026-06-18","kind":"grant","planned":false,"acquired":true,"shares":2340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders."}],"balance_after":2340,"derivative":{"exercise_price":2.02,"expiration_date":"2036-06-17","underlying":"Common Stock","underlying_shares":2340},"source":{"system":"sec-edgar","filing":"0000905148-26-003048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000090514826003048/form4.xml","form_type":"4"}},{"id":1102814,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T20:30:49.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2026 and the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":18700,"derivative":{"exercise_price":0.47,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000905148-25-002243","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000090514825002243/form4.xml","form_type":"4"}},{"id":1137777,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2025-05-22T20:12:48.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":14400,"price":3.13,"value":45072.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2025 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 28, 2025, contingent upon shareholder approval of Curis's Amendment No. 1 to the Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if Amendment No. 1 to the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 20, 2025, at the 2025 annual meeting of shareholders, Curis's shareholders approved Amendment No. 1 to the Fifth Amended and Restated 2010 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026."}],"balance_after":14400,"derivative":{"exercise_price":3.13,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":14400},"source":{"system":"sec-edgar","filing":"0001108205-25-000064","document":"wk-form4_1747944760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820525000064/wk-form4_1747944760.xml","form_type":"4"}},{"id":1159473,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-05-05T21:45:10.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":15938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reported transactions represent the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan and 2021 Equity Inducement Plan, in connection with her separation and transition from her position with the issuer, as previously reported by the issuer in its Current Report filed with the Securities and Exchange Commission on Form 8-K on March 13, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":17812,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":15938},"source":{"system":"sec-edgar","filing":"0001415889-25-011996","document":"form4-05052025_090507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925011996/form4-05052025_090507.xml","form_type":"4"}},{"id":1159472,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-05-05T21:45:10.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":false,"shares":53125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reported transactions represent the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan and 2021 Equity Inducement Plan, in connection with her separation and transition from her position with the issuer, as previously reported by the issuer in its Current Report filed with the Securities and Exchange Commission on Form 8-K on March 13, 2025."}],"balance_after":21875,"derivative":{"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":53125},"source":{"system":"sec-edgar","filing":"0001415889-25-011996","document":"form4-05052025_090507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925011996/form4-05052025_090507.xml","form_type":"4"}},{"id":1159471,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-05T21:45:10.000Z","date":"2025-05-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":24709,"price":1.07,"value":26438.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":97452,"source":{"system":"sec-edgar","filing":"0001415889-25-011996","document":"form4-05052025_090507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925011996/form4-05052025_090507.xml","form_type":"4"}},{"id":1159470,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-05T21:45:10.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":15938,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122161,"source":{"system":"sec-edgar","filing":"0001415889-25-011996","document":"form4-05052025_090507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925011996/form4-05052025_090507.xml","form_type":"4"}},{"id":1159469,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-05-05T21:45:10.000Z","date":"2025-05-01","kind":"exercise","planned":false,"acquired":true,"shares":53125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":106223,"source":{"system":"sec-edgar","filing":"0001415889-25-011996","document":"form4-05052025_090507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925011996/form4-05052025_090507.xml","form_type":"4"}},{"id":1229551,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T22:57:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":33750,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1229550,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2025-03-04T22:57:10.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1229549,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T22:57:10.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4621,"price":1.59,"value":7347.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":53098,"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1229548,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T22:57:10.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57719,"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1229547,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T22:57:10.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":15405,"price":1.59,"value":24493.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":46469,"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1229546,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T22:57:10.000Z","date":"2025-02-28","kind":"exercise","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":61874,"source":{"system":"sec-edgar","filing":"0001415889-25-006655","document":"form4-03042025_100306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588925006655/form4-03042025_100306.xml","form_type":"4"}},{"id":1291026,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2025-01-30T21:05:28.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":1600,"price":3.13,"value":5008.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 28, 2026."}],"balance_after":1600,"derivative":{"exercise_price":3.13,"expiration_date":"2035-01-27","underlying":"Common Stock","underlying_shares":1600},"source":{"system":"sec-edgar","filing":"0001108205-25-000008","document":"wk-form4_1738271120.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820525000008/wk-form4_1738271120.xml","form_type":"4"}},{"id":1472260,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T21:03:29.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":18700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":18700,"derivative":{"exercise_price":1.5,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":18700},"source":{"system":"sec-edgar","filing":"0000905148-24-001764","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000090514824001764/form4.xml","form_type":"4"}},{"id":1504125,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2024-05-23T20:08:58.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4250,"price":11.62,"value":49385.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option grant, as disclosed in Curis Inc.'s 2024 proxy statement, was approved by the Board of Directors of Curis, Inc. on January 20, 2024, contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan to increase the number of shares authorized for issuance thereunder; and further provided that such option would not be exercisable and no common stock would be issued thereunder, if the Fifth Amended and Restated 2010 Plan was not approved by Curis's shareholders. On May 21, 2024, at the 2024 annual meeting of shareholders, Curis's shareholders approved the Fifth Amended and Restated 2010 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option grant described in this Form 4 filing vests as to 100% of the underlying shares on January 20, 2025."}],"balance_after":4250,"derivative":{"exercise_price":11.62,"expiration_date":"2034-01-19","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001108205-24-000050","document":"wk-form4_1716494923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820524000050/wk-form4_1716494923.xml","form_type":"4"}},{"id":1589395,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-03-07T21:24:32.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date."}],"balance_after":45000,"derivative":{"expiration_date":"2028-03-01","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-24-007182","document":"form4-03072024_090326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588924007182/form4-03072024_090326.xml","form_type":"4"}},{"id":1589394,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-07T21:24:32.000Z","date":"2024-03-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":60000,"derivative":{"exercise_price":4.54,"expiration_date":"2034-03-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-007182","document":"form4-03072024_090326.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588924007182/form4-03072024_090326.xml","form_type":"4"}},{"id":1603604,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2024-03-04T21:15:38.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date."}],"balance_after":112500,"derivative":{"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001415889-24-006267","document":"form4-03042024_090339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588924006267/form4-03042024_090339.xml","form_type":"4"}},{"id":1603603,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-04T21:15:38.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":13126,"price":4.91,"value":64448.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":24374,"source":{"system":"sec-edgar","filing":"0001415889-24-006267","document":"form4-03042024_090339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588924006267/form4-03042024_090339.xml","form_type":"4"}},{"id":1603602,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-03-04T21:15:38.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001415889-24-006267","document":"form4-03042024_090339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000141588924006267/form4-03042024_090339.xml","form_type":"4"}},{"id":1845485,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-23T20:30:35.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 22, 2024 and the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":1.62,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001140361-23-031187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000114036123031187/form4.xml","form_type":"4"}},{"id":1947598,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit (RSU)","published_at":"2023-03-17T20:05:19.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total shares annually beginning on February 28, 2024, subject to continued service through each vesting date."}],"balance_after":150000,"derivative":{"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-019599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000120919123019599/doc4.xml","form_type":"4"}},{"id":1947597,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy Common Stock)","published_at":"2023-03-17T20:05:19.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4th of the total shares on February 28, 2024 and then 1/48th of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 28, 2027, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":5.4,"expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-019599","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000120919123019599/doc4.xml","form_type":"4"}},{"id":2047768,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2023-01-24T21:12:13.000Z","date":"2023-01-23","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the 2010 Amended and Restated Stock Incentive Plan and will vest as to 100% of the underlying shares on the first anniversary of the date of grant (January 23, 2024), subject to the director's continued service with the Company."}],"balance_after":85000,"derivative":{"exercise_price":0.75,"expiration_date":"2033-01-22","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001108205-23-000012","document":"wf-form4_167459471417943.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000110820523000012/wf-form4_167459471417943.xml","form_type":"4"}},{"id":2137219,"issuer":{"id":8401,"kind":"organization","name":"CURIS INC"},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2022-10-14T20:06:54.000Z","date":"2022-10-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options granted under the Fourth Amended and Restated 2010 Stock Incentive Plan and will vest over a period of four years with 25% of the shares underlying the stock option vesting on October 12, 2023, and an additional 6.25% of the shares vesting at the end of each successive three-month period thereafter until the options are fully vested on October 12, 2026, subject to Dr. Borgman's continued service on the Company's Board."}],"balance_after":25000,"derivative":{"exercise_price":0.73,"expiration_date":"2032-10-11","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-053658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1108205/000120919122053658/doc4.xml","form_type":"4"}},{"id":2222249,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T21:32:02.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":14250,"derivative":{"exercise_price":4.77,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001567619-22-013372","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000156761922013372/doc1.xml","form_type":"4"}},{"id":2549522,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T20:05:03.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders."}],"balance_after":10384,"derivative":{"exercise_price":7.56,"expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001567619-21-017920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000156761921017920/doc1.xml","form_type":"4"}},{"id":2549521,"issuer":{"id":7461,"kind":"organization","name":"NextCure, Inc."},"owners":[{"id":31277,"kind":"person","name":"Borgman Anne Elizabeth","position":1,"cik":"0001886388","reported_name":"Borgman Anne Elizabeth","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T20:05:03.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on October 1, 2021."}],"balance_after":28500,"derivative":{"exercise_price":7.56,"expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001567619-21-017920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1886388/000156761921017920/doc1.xml","form_type":"4"}}]}